Alnylam Pharmaceuticals holds the cleaner structural position, with the lead spread across profitability and stability. Affirm still has the edge on valuation, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
The clearest separation starts in profitability, but stability adds another real layer to the result. Alnylam Pharmaceuticals, Inc. leads by 24 points on the overall comparison score.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The clearest structural overlap shows up in investment intensity and margin trend.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The price setup looks more supportive for Alnylam Pharmaceuticals, Inc., but Affirm Holdings, Inc. still has the stronger structure.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 62-point ROIC advantage.
Absolute pricing still looks more supportive for Affirm, with a forward P/E that is 11.2 turns lower there.
The lead is built on both profitability and stability — though valuation still provides a counterweight.
Break down the AFRM vs ALNY comparison across all dimensions with the full interactive tool.
Explore how AFRM and ALNY each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.